GTHP - Guided Therapeutics, Inc.

OTC BB - OTC BB Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue244605606
Cost of Revenue530493537
Gross Profit-28611269
Operating Expenses
Research Development3347331,477
Selling General and Administrative2,5013,1994,819
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-3,121-3,820-6,227
Income from Continuing Operations
Total Other Income/Expenses Net-6,4691,745642
Earnings Before Interest and Taxes-9,590-2,075-5,585
Interest Expense1,1061,8951,317
Income Before Tax-10,696-3,970-6,902
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-10,696-3,970-6,902
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,696-3,970-6,902
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,974-4,995-9,503